GlassScriptPhysician profile
Bruce M Freedman
NPI 1316922503
$2,256.25
in general payments reported to CMS, 2019-2025
13 companies · $14.41 in 2025
The $14.41 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $470 · 2020: $386 · 2021: $154 · 2022: $388 · 2023: $199 · 2024: $645 · 2025: $14.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $836 · Travel and Lodging: $21.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $836.11 |
| Travel and Lodging | $21.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $800.37 | 2019-2024 | Tenoglide, Integra, Integra Dermal Regeneration Template |
| Merz North America, INC. | $415.41 | 2019-2023 | |
| Stryker Corporation | $246.21 | 2020-2024 | Conextions Tr Tendon Repair System-Implant Mechanism |
| Kerecis Limited | $208.69 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Lumenis Be INC | $165.05 | 2024 | Optilight |
| Derma Sciences, INC. | $144.71 | 2019 | |
| Depuy Synthes Sales INC. | $118.62 | 2020 | |
| Galderma Laboratories, L.P. | $49.39 | 2020-2023 | Dysport |
| Tela Bio, INC. | $38.29 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $23.84 | 2019 | |
| Mentor Worldwide LLC | $18.80 | 2021 | |
| Access Pro Medical, LLC | $14.41 | 2025 | Matriderm |
| Organogenesis INC. | $12.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Freedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.